Drug Delivery Implants Well-Positioned for Growth in Cancer, Pain Management
Posted on: Monday, 19 September 2005, 09:00 CDT
Drug delivery implants are increasingly being recognized as useful drug delivery systems that can provide greater assurance of patient compliance and better therapeutic outcomes than conventional drug therapies, particularly for chronic medication. Interest in implants has increased as current-generation devices have demonstrated their durability, reliability and biocompatibility. As healthcare strategists seek reliable ways to treat an increasingly aging, fragile and forgetful population, the allure of implants will continue to grow.
The market for implants will be driven by the need for improved patient compliance in the treatment of chronic conditions, and evolving advances in synthetic materials and implant design. "The current generation of drug delivery implants, consisting primarily of rigid geometric structures and polymer-based systems that release drugs continuously over extended periods of time, will be joined by future devices that will incorporate micro and nanostructures," explains George Perros, Greystone Associates Managing Director. These new devices hold the promise of such capabilities as variable rate delivery and physical and/or biological activation. "We expect drug delivery implants to expand into new therapeutic areas as drug companies search for ways to extend patent protection for existing drugs," adds Perros.
These findings are contained in a new and comprehensive report, Drug Delivery Implants: Therapies, Technology, and Opportunities. The growth of implants will be driven by a number of factors, including patient demographics and innovative technology solutions that address recognized needs in chronic disease therapeutics.
More information is available at www.greystoneassociates.org .
About Greystone
Greystone Associates is a medical and healthcare technology consulting firm providing services in strategic planning, venture development, product commercialization, and technology and market assessment.
Source: Business Wire
Related Articles
- West Acquires Drug Delivery Assets From Plastef Investissements SA
- Hackers might harm drug delivery devices
- Examine Injectable Drug Delivery Technologies, Targets and Therapeutics With This Essential and Comprehensive Report
- Breakthrough in Pulmonary Drug Delivery Will Bring Numerous In-Hospital Treatments to the Home
- Kurve Technology Launches Nasal Drug Delivery Blog
- Metered Dose Inhalers Still the Workhorse of Respiratory Drug Delivery
- AerovectRx Corp. To Present Latest in Nebulizer Drug Delivery Technology at In3 Medical Device Summit; FDA 510(K) Clearance Recently Granted for Novel, Efficient and Disposable Vibrating Mesh Technology
- Scientists Use Wireless MicroCHIPS To Control Drug Release in Vivo; ''Intelligent'' Drug Delivery Devices on Horizon
- Review Article Indicated That Optimal Device Choice for Pediatric Asthma Drug Delivery Is the One Patients Prefer
- For Injectable Drug Delivery, Drug Companies Must Keep Both Eyes on End User
 |
 |
User Comments (0)
RSS Feeds